Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.79
+0.41 (6.43%)
Apr 14, 2026, 12:27 PM EDT - Market open
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $503.05 million as of April 14, 2026. Its market cap has increased by 268.70% in one year.
Market Cap
503.05M
Enterprise Value
298.79M
1-Year Change
268.70%
Ranking
Category
Stock Price
$6.79
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $503.05M, an increase of 85.38%. That is a compound annual growth rate of 28.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 472.68M | -34.78% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 456.00M |
| REGENXBIO | 454.23M |
| vTv Therapeutics | 453.69M |
| Atea Pharmaceuticals | 451.74M |
| Assembly Biosciences | 450.82M |
| YD Bio | 440.20M |
| XOMA Royalty | 437.78M |
| Aura Biosciences | 436.22M |